Pharma Spending Gone Bipolar: Generics At One End, Specialty Drugs on the Other
By Jane Sarasohn-Kahn on 23 April 2018 in Amazon, Business and health, Digital health, Digital therapeutics, FDA, Health costs, Health policy, Health politics, Health regulation, Healthcare access, Heart health, media and health, Medication adherence, Medicines, Money and health, Opioids, Pain, Patient experience, Personal health finance, Pharmaceutical, Pharmacy, Prescription drugs, Retail health, Shopping and health, Social networks and health, Specialty drugs, Wearable tech, Wearables
While the use of medicines continues to rise in the U.S., spending grew by only 0.6% in 2017 after accounting for discounts and rebates. In retail and mail-order channels, net spending fell by 2.1%. Prescription drug spending on branded products grew nearly $5 billion less than in 2016; generic drug spending fell by $5.5 billion, according to Medicine Use and Spending in the U.S., a report from the IQVIA Institute for Health Data Science. The report reviews medicines spending in 2017 looking forward to 2022. There were over 5.8 billion prescriptions dispensed in 2017, and generic drugs accounted 90% of
Jane will be working with EU- and UK-based clients in September and October 2026, collaborating with stakeholders in digital health, public/community health, retail health, and growing opportunities for health-at-home. Stay tuned to her updates here on Health Populi on-the-ground as she lives the digital nomadic work-life in Italy, Belgium, the Netherlands, and in London.
I was grateful to be Jasmine's first conversation-guest on her new podcast, "Aperture - Widen the Frame," where this expert in narrative medicine is bringing together the broad range of voices to sit at the table and address what health care needs: those humans in the health-system-loop who address health equity and empathy along with delivering evidence-based medicine for all.
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance. Click onto the Pfizer Value of Vaccines site and you can watch four episodes covering the challenges with adult vaccination, the employer and health plan member's journey to vaccination, reimbursement, and collaborating for proactive prevention.